Natural and revolutionary tumor-specific T-cell therapy
Abstract Recently the FDA conducted a risk investigation and labeled the Boxed Warning for all BCMA- and CD19-directed CAR-T cell therapy, so does it mean that the public must take risk of secondary cancer to receive cell therapy? Here, without lentivirus and professional antigen presenting cell app...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SpringerOpen
2024-08-01
|
| Serier: | Natural Products and Bioprospecting |
| Fag: | |
| Online adgang: | https://doi.org/10.1007/s13659-024-00472-w |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
